ATE368117T1 - Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung - Google Patents

Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung

Info

Publication number
ATE368117T1
ATE368117T1 AT00918668T AT00918668T ATE368117T1 AT E368117 T1 ATE368117 T1 AT E368117T1 AT 00918668 T AT00918668 T AT 00918668T AT 00918668 T AT00918668 T AT 00918668T AT E368117 T1 ATE368117 T1 AT E368117T1
Authority
AT
Austria
Prior art keywords
vaccine strain
anemia virus
equine infectious
infectious anemia
application
Prior art date
Application number
AT00918668T
Other languages
English (en)
Inventor
Yiming Shao
Rongxian Shen
Gang Chen
Kangzhen Yu
Pinliang Pan
Bin Jia
Yi Feng
Fei Xue
Wenhua Xiang
Xiujuan Fan
Xiaoling Lue
Liping Zhao
Original Assignee
Nat Ct For Aids Prevention And
Harbin Veterinary Res Inst Chi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Ct For Aids Prevention And, Harbin Veterinary Res Inst Chi filed Critical Nat Ct For Aids Prevention And
Application granted granted Critical
Publication of ATE368117T1 publication Critical patent/ATE368117T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00918668T 1999-04-21 2000-04-21 Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung ATE368117T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB991058526A CN1173036C (zh) 1999-04-21 1999-04-21 马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列

Publications (1)

Publication Number Publication Date
ATE368117T1 true ATE368117T1 (de) 2007-08-15

Family

ID=5272155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918668T ATE368117T1 (de) 1999-04-21 2000-04-21 Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung

Country Status (8)

Country Link
US (1) US6987020B1 (de)
EP (1) EP1174507B1 (de)
CN (1) CN1173036C (de)
AT (1) ATE368117T1 (de)
AU (1) AU3955400A (de)
DE (1) DE60035680T2 (de)
ES (1) ES2288848T3 (de)
WO (1) WO2000063387A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8710301A (en) * 2000-09-09 2002-03-22 Akzo Nobel Nv Eiav chimeric vaccine and diagnostic
US6461616B1 (en) * 2000-09-09 2002-10-08 Akzo Nobel Nv EIAV p26 deletion vaccine and diagnostic
CN101705246B (zh) * 2007-04-29 2012-06-27 中国农业科学院哈尔滨兽医研究所 慢病毒基因转移载体、其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491930B1 (de) 1990-07-12 1997-01-15 The President And Fellows Of Harvard College Primaten-lentivirus impfstoffe
CN1059701C (zh) * 1996-04-03 2000-12-20 中国农业科学院哈尔滨兽医研究所 马传染性贫血病驴白细胞弱毒株及其培育方法
EP0914422B1 (de) * 1996-04-15 2009-11-18 Vanderbilt University Säugetiergene, die an der viralen infektion beteiligt sind
CA2288328A1 (en) 1997-05-13 1998-11-19 University Of North Carolina At Chapel Hill Lentivirus-based gene transfer vectors
DE69738969D1 (de) * 1997-12-30 2008-10-16 Univ Minas Gerais Verfahren zur expression und herstellung des rekombinanten proteins gp90 der glykoproteinhülle des infektiösen pferdeanämievirus eiav

Also Published As

Publication number Publication date
EP1174507B1 (de) 2007-07-25
DE60035680D1 (de) 2007-09-06
CN1173036C (zh) 2004-10-27
AU3955400A (en) 2000-11-02
US6987020B1 (en) 2006-01-17
WO2000063387A1 (fr) 2000-10-26
ES2288848T3 (es) 2008-02-01
CN1271015A (zh) 2000-10-25
EP1174507A1 (de) 2002-01-23
DE60035680T2 (de) 2008-04-30
EP1174507A4 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
DE69941820D1 (en) Rekombinante newcastle-disease-virus rna expressionssysteme und impfstoffe
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
FR11C0027I2 (fr) Virus de l'influenza recombinants pour vaccins et traitement genetique
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DK0702085T3 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
WO2005056584A3 (fr) Nouvelle souche de coronavirus associe au sras et ses applications.
DE69836395D1 (de) Primern zum Nachweis von HIV-1
DE69028951T2 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
DE60331758D1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
ATE362538T1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
ATE368117T1 (de) Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung
EP1911853A3 (de) Nukleinsäuresequenzen, die als Primer und Sonden zur Amplifizierung und zum Nachweis des SARS-Koronavirus verwendet werden können
AR021143A1 (es) Identificacion de genotipos senv
WO1999057284A3 (en) Attenuated influenza viruses
ATE438714T1 (de) Molekulare klone mit mutierten hiv gag/pol, siv gag und siv env gene
PT1383796E (pt) Estirpe neurovirulenta do vírus do nilo ocidental e as suas aplicações
Nerurkar et al. Specificity of an oligonucleotide primer pair and of a single-base substitution in the amplification and detection of env gene sequences of HTLV-I variants from Papua New Guinea and the Solomon Islands
ATE557091T1 (de) Moleküle von hdv-nukleinsäuren, ihre fragmente und anwendungen
DK1254663T3 (da) Antivirusmiddel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1174507

Country of ref document: EP